<DOC>
	<DOCNO>NCT00374465</DOCNO>
	<brief_summary>The aim study compare effect treatment verapamil carvedilol long-term outcome stable , chronic heart failure secondary non-ischemic cardiomyopathy .</brief_summary>
	<brief_title>Therapy With Verapamil Carvedilol Chronic Heart Failure</brief_title>
	<detailed_description>Heart failure , irrespective etiology may view progressive disorder initiate different event sustain multifaceted pathophysiological mechanism . Regardless nature initiate event optimized therapy use , loss functioning cardiac myocytes develop disease progress . One potential explanation progression pathological mechanism underlie disease antagonize enough currently use therapeutic strategy . Accordingly , impaired myocardial perfusion secondary microvascular dysfunction postulate play major role progression heart failure despite standard therapy heart failure . It hypothesize diffuse subendocardial ischemia due alter coronary physiology may contribute global cardiac dysfunction see heart failure patient . Accordingly , coronary endothelial dysfunction microvascular epicardial level patient acute-onset idiopathic dilate cardiomyopathy chronic congestive heart failure report . Thus , take mentioned account , improvement endothelial function diminish subendocardial ischemia calcium antagonist may promise term use drug therapy patient stable chronic heart failure . The previous randomize study ( 5 ) long-term pilot study support point view .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Cardiomyopathies</mesh_term>
	<mesh_term>Cardiomyopathy , Dilated</mesh_term>
	<mesh_term>Carvedilol</mesh_term>
	<mesh_term>Verapamil</mesh_term>
	<criteria>Chronic heart failure ( NYHA II III ; LV ejection fraction , â‰¤ 35 % ) secondary nonischemic cardiomyopathy Stable condition least 6 month enrollment conventional therapy ( betablockers , ACE inhibitor diuretic ) . Improvement clinical status conventional therapy outpatient period precede hospitalization , Any change narrow epicardial coronary artery coronary angiography , Insulin dependent diabetes , Valvular heart disease ( except relative mitral regurgitation ) , Endocrine disease Significant renal liver disease Alcohol abuse Lack write informed consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2006</verification_date>
	<keyword>Dilated Cardiomyopathy</keyword>
	<keyword>Heart Failure</keyword>
</DOC>